terfenadine has been researched along with Atherogenesis in 1 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In order to elucidate how pharmacological inhibition of histamine receptor 1 (H1R) signaling affects atherogenesis, we administered either cetirizine (1 and 4 mg/kg." | 3.80 | Chronic ingestion of H1-antihistamines increase progression of atherosclerosis in apolipoprotein E-/- mice. ( Dileepan, KN; Flynn, CA; Milne, G; Raveendran, VV; Reed, GA; Smith, DD; Sweeney, ME; Tan, X; Tawfik, OW, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raveendran, VV | 1 |
| Smith, DD | 1 |
| Tan, X | 1 |
| Sweeney, ME | 1 |
| Reed, GA | 1 |
| Flynn, CA | 1 |
| Tawfik, OW | 1 |
| Milne, G | 1 |
| Dileepan, KN | 1 |
1 other study available for terfenadine and Atherogenesis
| Article | Year |
|---|---|
Chronic ingestion of H1-antihistamines increase progression of atherosclerosis in apolipoprotein E-/- mice.
Topics: Analysis of Variance; Animals; Apolipoproteins E; Atherosclerosis; Blood Chemical Analysis; CD36 Ant | 2014 |